Medcura, Inc.
Amendment
CIK: 0001672180·Biotechnology·DELAWARE·Filed: Jul 24, 2024
Total Offering
$22,800,000
Amount Sold
$22,486,953
Investors
151
First Sale
Jul 29, 2022
Offering Details
- Type
- Equity, Debt, Option to Acquire, Security to be Acquired, Other: Convertible Promissory Notes; Common Stock or Series A-1 Preferred Stock underlying the convertible promissory notes.
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Jim Buck | Related Person |
| Larry Tiffany | Related Person |
| Matthew Dowling, Ph.D | Related Person |
| Rich Vincent | Related Person |
| Abbas Ardehali, M.D. | Related Person |
Company
SEC Filing
0000929638-24-002569
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free